Cornell researchers designed a micro-sized artificial cilial system that could eventually enable low-cost, portable diagnostic devices for testing blood samples, manipulating cells or assisting in microfabrication processes.
For the colorful, graceful sea fans swaying among the coral reefs in the waters around Puerto Rico, copper is an emerging threat in an era of warming oceans, according to new Cornell research.
Weill Cornell Medicine has received a $45.3 million renewal grant from the National Institutes of Health’s Clinical and Translational Science Awards Program.
Many Graduate School students, alumni and staff have learned to use remote and hybrid environments to their benefit, creating a broader diversity of panelists and participants for online professional development programs.
A new study identifies some of the most critical genes that may drive a rare but deadly liver cancer, providing a road map for developing drugs that target those genes.
As hospitals and emergency departments urge more patients to stay home to avoid exposing themselves to COVID-19, patient care is moving to “telemedicine,” using web-based video and audio technology.
In New York City Nov. 12, a wave of chants, horns, sirens and signs, along with the Big Red Band, marked the 22nd Sy Katz '31 Parade down Fifth Avenue.
As the world enters a third year of pandemic-related uncertainties, one thing does seem certain: The SARS-CoV-2 virus mutates and keeps us on our toes.
A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to Weill Cornell Medicine researchers.